Pancreatic Cancer Europe posted on LinkedIn:
“PCE is pleased to share the summary report from María Belén Toledo Cutillas following her research stay at GENYO.
Pfizer-University of Granada-Junta de Andalucia Center for Genomics and Oncological Research, focused on extracellular vesicle (EV)-mediated communication in early pancreatic ductal adenocarcinoma (PDAC).
This work lays the groundwork for future research into EV-based biomarkers, early diagnosis and personalised medicine in pancreatic cancer.
We are proud to support research that advances scientific knowledge and strengthens international collaboration.
Read the full report on our website.”
Other articles about Pancreatic Cancer Europe on OncoDaily.
